The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils.
The presence of vacuolar H(+)-ATPase (V-ATPase) on exocytotic granules in eosinophils and the role of this enzyme in exocytosis were explored in this study. Antibody against 116-kd subunit of V-ATPase positively stained eosinophil granules in immunofluorescence analysis. When eosinophil lysate was extracted immunomagnetically with the same antibody, the extracted fraction contained a considerable amount of eosinophil peroxidase, a marker of eosinophil-specific granules, which indicates that V-ATPase was present on the membranes of eosinophil exsosomal granules. The pH of the eosinophil granules, measured fluorometrically with acridine orange as a delta pH-sensitive dye, was estimated to be 5.1. The acidity of the eosinophil granules was perturbed by bafilomycin A1, a potent selective inhibitor of V-ATPase, which indicates that the low pH of these granules is maintained by V-ATPase activity. BafilomycinA1 and NH4Cl, both of which raise the intragranular pH to neutral, inhibited the eosinophil peroxidase exocytosis induced by platelet-activating factor. These agents did not, however, affect the changes in cytosolic free calcium concentration [Ca2+]i induced by platelet-activating factor. These observations suggest that bafilomycin A1 inhibited a delta pH-requiring step in eosinophil exocytosis that was preceded by the [Ca2+]i transient in the signal transduction pathway, and, hence, the findings suggest the pivotal role of V-ATPase in maintaining intragranular pH and its function of eosinophil exosomal granules.
Kurashima
K
K
Third Department of Internal Medicine, Kanazawa University, School of Medicine, Japan.
Numata
M
M
Yachie
A
A
Sai
Y
Y
Ishizaka
N
N
Fujimura
M
M
Matsuda
T
T
Ohkuma
S
S
D000643:Ammonium Chloride / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003594:Cytoplasmic Granules / Q000737:chemistry / Q000201:enzymology*; D004804:Eosinophils / Q000201:enzymology / Q000502:physiology*; D005089:Exocytosis / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007150:Immunohistochemistry; D018942:Macrolides; D010972:Platelet Activating Factor / Q000494:pharmacology; D006180:Proton-Translocating ATPases / Q000097:blood / Q000276:immunology / Q000502:physiology*; D025262:Vacuolar Proton-Translocating ATPases
D000900:Anti-Bacterial Agents; D018942:Macrolides; D010972:Platelet Activating Factor; D000643:Ammonium Chloride; C057620:bafilomycin A; D025262:Vacuolar Proton-Translocating ATPases; D006180:Proton-Translocating ATPases; D002118:Calcium